Bio Pappel, S.A.B. de C.V. announced unaudited consolidated financial results for the second quarter and first half of 2013. EBITDA was $74.3 million in the first half of the year against $43.4 million reported in the same period of 2012, due to higher Selling Price for 4.8% and lower Unit Cost for 4.0%. As for Bio Pappel's financial reliability it continues to increase as a result of its financial structure and the strengthening of its cash flow generation.

The company reported EBITDA of $34.1 million during the second quarter of 2013 against $27.0 million reported in second quarter of 2012, representing a 26.4% increase. In second quarter of 2013, the company's net debt declined significantly, reaching $139.6 million, which coupled with the EBITDA growth, resulted in its financial structure strengthening with an interest coverage ratio of 8.0 times in the last twelve months, which ratios are equivalent to Investment Grade Rating.